ROIV

Roivant Sciences is a biotechnology company developing new medicines to treat autoimmune and inflammatory diseases. The company's main focus is on drugs still in clinical testing, including treatments for pulmonary hypertension, thyroid eye disease, rheumatoid arthritis, and several other immune-related conditions. Roivant also develops delivery platforms, which are the technologies used to get medicines into patients' bodies effectively. The company was founded in 2014 and is based in London.